These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24673339)

  • 21. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre.
    Wolf G; Busch M; Müller N; Müller UA
    Nephrol Dial Transplant; 2011 Dec; 26(12):4017-23. PubMed ID: 21493815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
    Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
    Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Klin Med (Mosk); 2010; 88(1):32-7. PubMed ID: 20369609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
    Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M
    Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.
    Kim DM; Ahn CW; Park JS; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S169-72. PubMed ID: 15563971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.
    Bentata Y; Chemlal A; Karimi I; El Alaoui F; Haddiya I; Abouqal R
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):1035-43. PubMed ID: 26354588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of metabolic syndrome slows progression of diabetic nephropathy.
    Duran-Perez EG; Almeda-Valdes P; Cuevas-Ramos D; Campos-Barrera E; Muñoz-Hernandez L; Gomez-Perez FJ
    Metab Syndr Relat Disord; 2011 Dec; 9(6):483-9. PubMed ID: 21875335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albuminuria and glomerular filtration rate in type 2 diabetes mellitus.
    Magri CJ; Fava S
    Minerva Urol Nefrol; 2011 Dec; 63(4):273-80. PubMed ID: 21996982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal function changes in hypertensive patients with non-insulin- dependent diabetes mellitus.
    Rius F; Pizarro E; Castells I; Salinas I; Sanmartí A; Romero R
    Kidney Int Suppl; 1996 Jun; 55():S88-90. PubMed ID: 8743520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain in adiposity over 3 years is associated with progressive renal decline in multi-ethnic South-east Asians with type 2 diabetes.
    Moh MC; Sum CF; Tavintharan S; Ang K; Kwan PY; Lee SBM; Tang WE; Lim SC
    J Diabetes; 2019 Apr; 11(4):316-325. PubMed ID: 30178527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Diabet Med; 2010 May; 27(5):538-43. PubMed ID: 20536949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment.
    Rigalleau V; Lasseur C; Perlemoine C; Barthe N; Raffaitin C; Chauveau P; Combe C; Gin H
    Metabolism; 2006 Jan; 55(1):108-12. PubMed ID: 16324928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy?
    Kuricová K; Tanhäuserová V; Pácal L; Bartáková V; Brožová L; Jarkovský J; Kaňková K
    Kidney Blood Press Res; 2013; 38(1):92-8. PubMed ID: 24603156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between obesity and diabetic nephropathy in China.
    Chen HM; Shen WW; Ge YC; Zhang YD; Xie HL; Liu ZH
    BMC Nephrol; 2013 Mar; 14():69. PubMed ID: 23521842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.